Published in Medical Letter on the CDC and FDA, November 25th, 2001
In response to a request for information from the U.S. Department of Health and Human Services (HHS) and the U.S. Centers for Disease Control and Prevention (CDC), Aventis Pharma offered its support in ensuring an adequate supply of smallpox vaccine. In upcoming meetings with administration officials, the company will present its proposal regarding smallpox vaccine, as well as offer scientific and technical support for the development of new vaccines and antibiotic manufacturing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.